Devices/Safety Alert·FDA MedWatch Safety Alerts

Convenience Kit Recall: Aligned Medical Solutions Removes Convenience Kits Containing Namic RA Syringes

HighPublished May 11, 2026· AI-analyzed May 11, 2026View original FDA source
AI-generated regulatory interpretation. The four sections below are an analyst-style summary produced by an AI model from the original FDA source. Always verify against the source before any regulatory, clinical, or commercial decision.
What happened

Aligned Medical Solutions has initiated a recall for convenience kits containing Namic RA syringes because the syringe adaptors may unwind during use. This mechanical failure can result in a loose connection or complete disconnection.

Who it affects

This affects Aligned Medical Solutions, healthcare providers utilizing the convenience kits, and clinical personnel involved in procedures where Namic RA syringes are used.

Why it matters

The failure of a syringe adaptor represents a significant safety risk, as the source indicates potential for infection, air embolism, or blood loss. From a regulatory perspective, this highlights the liability and oversight responsibilities of kit manufacturers for third-party components included in a single-use assembly. The severity of the potential clinical outcomes suggests this may be classified as a high-priority recall event.

Practical takeaway

Quality teams should immediately identify and sequester any Aligned Medical Solutions convenience kits containing Namic RA syringes. Regulatory and risk management departments should evaluate internal procedures for monitoring the component reliability of third-party products integrated into convenience kits. Affected facilities should follow established recall protocols to prevent the use of these units.

FDA source material

The adaptor on Namic RA syringes may unwind during use. The resulting loose connection or disconnection may lead to infection, blood loss, or air embolism.

Open in openFDA / FDA.gov
AI-generated interpretation. Always verify critical decisions against the original FDA source. Generated with google/gemini-3-flash-preview.